With the World Health Organization (WHO) officially declared the outbreak of the virus as a pandemic, a mix of established pharmaceutical companies, as well as players in the bioprocess containers market, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.
Growth in the bioprocess containers market is mainly driven by factors such as the growing biologics market, affordability and sustainability of single-use bioprocess technologies, and rising biopharmaceutical R&D. Emerging countries and the patent expiry of biologics are expected to offer growth opportunities for players operating in the bioprocess containers market during the forecast period.
Therefore, the growing adoption of single-use technologies for COVID-19 pandemic-related research, coupled with increasing vaccine development by key players, is expected to have a positive impact on the bioprocess containers market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832
The growth of single-use technologies can be attributed to the growing need for better, cheaper, and faster biologics production. Active development of individualized biologics and personalized medicines, including patient-specific cellular & gene therapies and therapeutic vaccines, demands high sterility and is therefore manufactured using single-use equipment and consumables.
According to a survey conducted by BioPlan Associates in 2018, 73.3% of respondents agreed that leachables and extractables are major concerns that may limit the use of bioprocessing in the near future. As single-use assembly products are made of processed plastic materials, they often face the problem of contamination from the container due to leachables.
Most single-use assemblies are made of multiple materials or layers, including polyethylene, polypropylene, ethylene vinyl alcohol, or nylon. Such products require extensive efforts to separate components into homogeneous components.
On the basis of application, the bioprocess containers market is segmented into upstream processes, downstream processes, and process development. In 2020, the upstream processes segment accounted for the largest share of the bioprocess containers market.